$1.15
00.00%
Pre-Market: Sep 20, 4:00 PM EDT
15 minutes delayed
Comments
Loading...
Ovid Therapeutics (OVID) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestOvid Therapeutics (NASDAQ:OVID) Stock Quotes, Forecast and News Summary
Ovid Therapeutics Stock (NASDAQ: OVID) stock price, news, charts, stock research, profile.
| Open | - |
| Close | - |
| Volume / Avg. | 0 / 525.75K |
| Day Range | - - - |
| 52 Wk Range | 0.68 - 4.10 |
| Market Cap | $81.62M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 52 |
| Short Interest | 1.23% |
| Days to Cover | 3.03 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Ovid Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and mean...
Show More
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Ovid Therapeutics (OVID) stock?
You can purchase shares of Ovid Therapeutics (NASDAQ:OVID) through any online brokerage.
Who are Ovid Therapeutics (OVID) competitors?
Other companies in Ovid Therapeutics’s space includes: Renovaro (NASDAQ:RENB), CytomX Therapeutics (NASDAQ:CTMX), bluebird bio (NASDAQ:BLUE), Cellectar Biosciences (NASDAQ:CLRB) and Armata Pharmaceuticals (AMEX:ARMP).
What is the forecast, or price target, for Ovid Therapeutics (OVID) stock?
Ovid Therapeutics has a consensus price target of $4.74.
What is the current price for Ovid Therapeutics (OVID)?
The stock price for Ovid Therapeutics (NASDAQ: OVID) is $1.15 last updated September 20, 2024 at 4:00 PM EDT.
Does Ovid Therapeutics (OVID) pay a dividend?
There are no upcoming dividends for Ovid Therapeutics.
When is Ovid Therapeutics (NASDAQ:OVID) reporting earnings?
Ovid Therapeutics’s Q3 earnings are confirmed for Friday, November 1, 2024.
Is Ovid Therapeutics (OVID) going to split?
There is no upcoming split for Ovid Therapeutics.
What sector and industry does Ovid Therapeutics (OVID) operate in?
Ovid Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.